What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
The scientist’s investigation covers issues in Internal medicine, Respiratory disease, Pathology, Cell biology and Anesthesia.
His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Surgery.
His research integrates issues of Pneumocystis carinii, Pneumonia and Radiology, Pulmonary hypertension, Pulmonary function testing in his study of Respiratory disease.
His Pathology research integrates issues from Central nervous system disease, Neuroscience and Lissencephaly.
Jeffrey A. Golden has included themes like Apoptosis, Anatomy, Bone morphogenetic protein and Bone morphogenetic protein 2 in his Cell biology study.
Jeffrey A. Golden has researched Anesthesia in several fields, including Bronchoalveolar lavage and Brain damage.
His most cited work include:
- The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. (1222 citations)
- Cyclophosphamide versus placebo in scleroderma lung disease. (1084 citations)
- Semaphorin III is needed for normal patterning and growth of nerves, bones and heart (508 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Lung, Pathology, Lung transplantation and Neuroscience.
His work deals with themes such as Gastroenterology, Endocrinology and Surgery, which intersect with Internal medicine.
The various areas that Jeffrey A. Golden examines in his Lung study include Radiology and Immunology.
Jeffrey A. Golden studies Pathology, focusing on Pathogenesis in particular.
Jeffrey A. Golden frequently studies issues relating to Cell migration and Neuroscience.
His Bronchoalveolar lavage study integrates concerns from other disciplines, such as Pharmacokinetics and Pneumocystis carinii.
He most often published in these fields:
- Internal medicine (25.00%)
- Lung (20.00%)
- Pathology (20.91%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (25.00%)
- Lung (20.00%)
- Lung transplantation (15.68%)
In recent papers he was focusing on the following fields of study:
Jeffrey A. Golden mostly deals with Internal medicine, Lung, Lung transplantation, Immunology and Idiopathic pulmonary fibrosis.
His Internal medicine research includes themes of Gastroenterology, Oncology and Histopathology.
His study in Lung is interdisciplinary in nature, drawing from both Biomarker, Transcriptome, Immune system and Pathology.
His work in Pathology addresses subjects such as Gene expression, which are connected to disciplines such as Allograft rejection and Downregulation and upregulation.
His Lung transplantation study combines topics in areas such as Prospective cohort study, Quality of life, Lung injury and Hazard ratio.
His work investigates the relationship between Idiopathic pulmonary fibrosis and topics such as FEV1/FVC ratio that intersect with problems in Exacerbation, Randomized controlled trial and Tolerability.
Between 2016 and 2021, his most popular works were:
- The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study (102 citations)
- Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen. (82 citations)
- Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial (75 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His primary areas of investigation include Internal medicine, Lung transplantation, Prospective cohort study, Idiopathic pulmonary fibrosis and Lung.
His Internal medicine study frequently draws connections between related disciplines such as Oncology.
The study incorporates disciplines such as Adoptive cell transfer, Lung injury and Endogeny in addition to Lung transplantation.
His Prospective cohort study research is multidisciplinary, incorporating perspectives in Proportional hazards model and Interstitial lung disease.
As a part of the same scientific family, Jeffrey A. Golden mostly works in the field of Idiopathic pulmonary fibrosis, focusing on FEV1/FVC ratio and, on occasion, Exacerbation, Tolerability and Randomized controlled trial.
The Lung study which covers Cellular Ageing that intersects with Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
